摘要
目的 探究对慢性心衰患者使用诺欣妥药物治疗时的临床效果和其对患者心功能治疗前后的影响分析以及应用价值。方法 本次研究的病例数为30例,均来源于2020年4月至2022年7月期间在本院接受治疗的慢性心衰患者,在研究期间将所有患者进行盲选分组,观察组接受诺欣妥药物治疗干预,对照组则接受常规治疗干预。在治疗期间统计两组患者的临床有效率(明显有效、有效、无效)和治疗前后的心功能指标(LVEDD、LVESD、LVEF)情况,并将研究数据进行组间对比分析。结果 对照组患者的临床有效率(60.00%)明显低于观察组患者的(93.33%);对照组患者的心功能指标情况{(56.88±3.91)、(46.35±3.55)、(37.27±4.64)}也明显不如观察组患者的{(47.39±4.39)、(40.44±3.32)、(48.66±5.73)},组间数值P<0.05,说明存在对比意义。结论 对慢性心衰患者使用诺欣妥药物治疗干预的临床效果十分显著,该项治疗措施能够明显改善患者的临床整体治疗有效性,促进改善患者的心功能指标情况,进而提升患者的生活质量评分,同时综合提高患者对其护理服务的满意度。
关键词: 诺欣妥治疗;慢性心衰;临床有效率;心功能指标;影响分析;应用价值
Abstract
Objective To explore the clinical effect of Nuxinto in the treatment of chronic heart failure patients, its influence on the heart function of patients before and after treatment, and its application value. Methods The number of cases in this study was 30, all from patients with chronic heart failure who were treated in our hospital from April 2020 to July 2022. All patients were blindly selected and grouped during the study period, and the observation group received Nuosinto drug treatment intervention, the control group received conventional treatment intervention. During the treatment period, the clinical effective rate (obviously effective, effective, ineffective) and cardiac function indexes (LVEDD, LVESD, LVEF) before and after treatment were counted in the two groups, and the research data were compared between groups. Results The clinical effective rate (60.00%) of the control group was significantly lower than that of the observation group (93.33%); the cardiac function indexes of the control group were {(56.883.91), (46.353.55), (37.274.64) )} was also significantly inferior to the patients in the observation group {(47.394.39), (40.443.32), (48.665.73)}, the value between groups was P<0.05, indicating that there was a comparative significance. Conclusion The clinical effect of using Nuoxinto drug treatment inter- vention in patients with chronic heart failure is very significant. This treatment measure can significantly improve the overall clinical treatment effectiveness of patients, promote the improvement of patients' cardiac function indicators, and then improve the quality of life of patients. score, and comprehensively improve patients' satis- faction with their nursing services.
Key words: Nuoxinto treatment; Chronic heart failure; Clinical efficacy; Cardiac function index; Impact analysis; Application value
参考文献 References
[1]孙瑛. 诺欣妥治疗慢性心衰的临床效果及对心功能的影响分析[J].中国现代药物应用,2022,16(08):69-73.
[2]李红云,董得刚,戴生喜,唐苗苗,徐聪. 血府逐瘀汤合玉苓散联合诺欣妥与传统的“金三角”治疗方案治疗血瘀脉阻证慢性心衰的临床疗效对比观察[J].四川中医,2021,39(11):101-112.
[3]苏桥慧. 超声评价诺欣妥治疗慢性心力衰竭患者的心脏功能[D].吉林大学,2021:178-188.
[4]骆元正. 诺欣妥对于慢性心衰的体征改善及临床效果[J].中国城乡企业卫生,2021,36(02):213-229.
[5]程希富,刘学谦,李学晋,王会珍,魏法权. 沙库巴曲缬沙坦治疗慢性心衰对患者心肾功能指标的影响[J].实用中西医结合临床,2021,21(02):287-288.
[6]秦丽英,李平宝,范尧,王俊杰. 诺欣妥对持续性房颤合并慢性心衰患者心功能和生活质量的影响[J].北方药学,2020,17(01):319-332.
[7]魏莉娜,王月平,朱秋霞,任星星,贾利清. 左西孟旦联合沙库巴曲缬沙坦钠对慢性心衰患者血流动力学和运动能力的影响[J].现代生物医学进展.2020,(22):443-445.
[8]牛希玲,靳小永,刘芳芳. 沙库巴曲缬沙坦联合瑞舒伐他汀对慢性心衰患者心室重构及血流动力学的影响[J].中国疗养医学.2020,(11):479-498.
[9]陈学彬,吉锋,李联社,赵明君. 温阳利水化瘀方联合西医常规疗法治疗慢性充血性心力衰竭阳虚血瘀证临床研究[J].中国中医药信息杂志.2019,(11):513-528.
[10]曲新华. 沙库巴曲缬沙坦钠联合贝那普利治疗慢性心衰的临床效果分析[J].中国现代药物应用,2022,16(09):556-559.